| Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00545311) | Novartis | 2007-07-01 |
| Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD. (NCT00496470) | AstraZeneca | 2007-05-01 |
| Improving Clinician Communication Skills (ICCS) (NCT00687349) | University of Washington | 2007-04-01 |
| COPD Research Registry (NCT01785706) | COPD Foundation | 2007-03-01 |
| Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00435760) | AstraZeneca | 2007-02-01 |
| Dyspnea Self-Management: Internet or Face-to-Face (NCT00461162) | University of California, San Francisco | 2007-01-01 |
| Electrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD) (NCT00874965) | Laval University | 2006-12-01 |
| Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036) (NCT00387036) | Merck Sharp & Dohme LLC | 2006-12-01 |
| A Structured Lifestyle Intervention on Daily Physical Activity Level in COPD (NCT00614796) | Groningen Research Institute for Asthma and COPD | 2006-11-01 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED) (NCT00383435) | Organon and Co | 2006-10-01 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED) (NCT00383721) | Organon and Co | 2006-09-01 |
| Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD) (NCT00358436) | AstraZeneca | 2006-08-01 |
| A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) (NCT00392587) | GlaxoSmithKline | 2006-08-01 |
| A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD) (NCT01021891) | Mannkind Corporation | 2006-07-01 |
| A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) (NCT00363896) | AstraZeneca | 2006-07-01 |
| Physical Training and Heart Rate Variability in COPD (NCT01889563) | Universidade Federal de Sao Carlos | 2006-05-01 |
| Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD (NCT00291408) | Imperial College London | 2006-04-01 |
| Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease (NCT00504738) | Weill Medical College of Cornell University | 2006-04-01 |
| Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125) (NCT00297115) | AstraZeneca | 2006-03-01 |
| Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) (NCT00288548) | Martini Hospital Groningen | 2006-02-01 |
| Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124) (NCT00297102) | AstraZeneca | 2006-02-01 |
| GR Defect in Sputum Cells in COPD (NCT00159276) | Imperial College London | 2005-12-01 |
| The Effects of a Home Exercise Video Programme for Patients With COPD (NCT00542932) | King's College Hospital NHS Trust | 2005-10-01 |
| Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00144859) | GlaxoSmithKline | 2005-07-01 |
| Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) (NCT00202176) | Queen's University | 2005-07-01 |
| Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08) (NCT00246935) | AstraZeneca | 2005-05-01 |
| Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06) (NCT00242294) | AstraZeneca | 2004-11-01 |
| Endothelial Dysfunction, Biomarkers, and Lung Function -Ancillary to MESA (NCT00843271) | Columbia University | 2004-10-01 |
| The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121) (NCT00108823) | AstraZeneca | 2004-10-01 |
| Sodium Pyruvate Therapy in COPD Patients (NCT00262613) | Emphycorp | 2004-09-01 |
| Magnesium Loading in Chronic Obstructive Pulmonary Disease (NCT00500864) | University of Sao Paulo | 2004-08-01 |
| Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT) (NCT00181285) | University of Chicago | 2003-10-01 |
| Evaluating Genes in Sputum to Measure Drug Response in COPD (NCT00233051) | National Jewish Health | 2003-04-01 |
| The Effect of Neuromuscular Electrical Stimulation (NCT00442728) | Provinciale Hogeschool Limburg | 2003-01-01 |
| Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD) (NCT00665600) | Sumitomo Pharma America, Inc. | 2002-02-01 |
| Tracheostomized COPD Patients and Non Invasive Mechanical Ventilation (NCT01285739) | Fondazione Salvatore Maugeri | 2002-01-01 |
| Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (NCT00164138) | Bayside Health | 2001-12-01 |
| Relative Potency of Inhaled Corticosteroids (NCT00292838) | St. Joseph's Healthcare Hamilton | 2001-01-01 |